JSE slips as investors mull vaccine news

The JSE was weaker on Tuesday, while its global counterparts were mixed as investors digest the news of the development of a coronavirus vaccine.

On Monday, drugmakers Pfizer and BioNTech announced that the preliminary results of their vaccine show it prevents more than 90% of infections, giving hope that there may be a return to economic normality in the coming months.

Source: businesslive.co.za